Free Trial

Aptevo Therapeutics (APVO) SEC Filings & 10K Form

Aptevo Therapeutics logo
$0.38 +0.07 (+22.62%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$0.35 -0.03 (-8.42%)
As of 07:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Aptevo Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
3:05 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
4:30 PM
Aptevo Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/13/2025
7:08 AM
Aptevo Therapeutics (Filer)
Form RW
05/13/2025
7:08 AM
Aptevo Therapeutics (Filer)
Form RW
04/29/2025
4:00 PM
Aptevo Therapeutics (Filer)
Form 424B5
04/28/2025
7:01 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
7:15 AM
Aptevo Therapeutics (Filer)
Form 424B4
04/18/2025
11:22 AM
Aptevo Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
04/10/2025
4:06 PM
Aptevo Therapeutics (Filer)
Form PRE 14A
04/10/2025
9:14 AM
Aptevo Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SCHEDULE 13G
04/09/2025
4:31 PM
Aptevo Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
04/08/2025
7:00 PM
Aptevo Therapeutics (Subject)
BIGGER CAPITAL FUND L P (Filed by)
Form SCHEDULE 13G
04/07/2025
3:51 PM
Aptevo Therapeutics (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Form SCHEDULE 13G
04/04/2025
3:15 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
9:10 AM
Aptevo Therapeutics (Filer)
Form 424B4
04/01/2025
5:51 AM
Aptevo Therapeutics (Filer)
Form S-1/A
03/27/2025
4:14 PM
Aptevo Therapeutics (Filer)
Form S-1/A
03/27/2025
6:23 AM
Aptevo Therapeutics (Filer)
Form S-1/A
03/25/2025
5:42 AM
Aptevo Therapeutics (Filer)
Form S-1/A
03/20/2025
7:44 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
5:12 AM
Aptevo Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
02/26/2025
11:15 PM
Aptevo Therapeutics (Filer)
Form EFFECT
02/14/2025
7:50 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
7:52 AM
Aptevo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/11/2025
7:37 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
5:58 PM
Aptevo Therapeutics (Subject)
Hudson Bay Capital Management LP (Filed by)
Form SCHEDULE 13G/A
01/02/2025
11:15 PM
Aptevo Therapeutics (Filer)
Form EFFECT
12/20/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/12/2024
4:15 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
8:05 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2024
7:45 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
4:05 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
7:45 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
7:45 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
7:45 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
1:57 PM
Aptevo Therapeutics (Subject)
Hudson Bay Capital Management LP (Filed by)
Form SC 13G
11/07/2024
7:30 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
7:15 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:48 PM
Aptevo Therapeutics (Filer)
Form PRE 14A
09/18/2024
3:07 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
A new financial chapter (Ad)

Porter Stansberry says what happened last week could become the defining legacy of his financial publishing career. In a special event watched by thousands, he unveiled what he calls “the boldest undertaking” he’s ever attempted — a real-money initiative that will document every trade, decision, win, and loss in pursuit of a million-dollar mission. And the results are already surprising. One early beta tester tripled her investment income in just three trades.

If you missed the event, he’s republishing the message he sent to attendees right after it ended.
09/17/2024
4:28 PM
Aptevo Therapeutics (Filer)
Form 424B4
09/16/2024
11:15 PM
Aptevo Therapeutics (Filer)
Form EFFECT
09/16/2024
7:09 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
4:26 PM
Aptevo Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/09/2024
3:30 PM
Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
3:33 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
3:35 PM
Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:30 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:15 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:32 PM
Aptevo Therapeutics (Issuer)
Niederhuber John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:34 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:35 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:35 PM
Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:36 PM
Aptevo Therapeutics (Issuer)
Grant Grady III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:37 PM
Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:38 PM
Aptevo Therapeutics (Issuer)
Harsanyi Zsolt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:30 PM
Abdun-Nabi Daniel (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:31 PM
Aptevo Therapeutics (Issuer)
Kunz Barbara Lopez (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:19 AM
Aptevo Therapeutics (Filer)
Form DEF 14A
07/12/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/03/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form PRE 14A
06/30/2024
11:15 PM
Aptevo Therapeutics (Filer)
Form EFFECT
06/26/2024
7:30 AM
Aptevo Therapeutics (Filer)
Form S-1/A
06/14/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/10/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
3:31 PM
Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APVO) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners